NYSE:PCG
NYSE:PCGElectric Utilities

Assessing PG&E After 24% 2025 Slide and Conflicting Valuation Signals

If you are wondering whether PG&E is a beaten down utility or a quiet value opportunity, this article will walk you through what the market might be missing and where the upside or downside could really lie. Despite a long term gain of 28.0% over 5 years, the stock is down 6.0% over the last week, 6.8% over the last month, and 24.2% year to date, leaving it roughly 25.0% lower than a year ago and firmly on value hunters' radars. These moves are happening as investors continue to weigh PG&E's...
NasdaqGS:HAS
NasdaqGS:HASLeisure

Hasbro (HAS) Valuation Check as Headquarters Relocation to Boston Signals a Strategic Shift

Hasbro (HAS) is shaking up its future by shifting its longtime Rhode Island headquarters to Boston, rolling out a phased move, new Seaport office space, and an aggressive hiring push through 2026. See our latest analysis for Hasbro. Against that backdrop, Hasbro’s 1 month share price return of 5.5 percent and 43.7 percent year to date share price gain suggest momentum is rebuilding. At the same time, a 3 year total shareholder return above 56 percent points to a still compelling long term...
NYSE:RCL
NYSE:RCLHospitality

Royal Caribbean (RCL): Is the Cruise Giant Undervalued After Its Recent 90‑Day Share Price Pullback?

Royal Caribbean Cruises (RCL) has quietly pulled back in recent weeks even though its year to date return is still in positive territory. That disconnect between recent weakness and longer term gains is worth unpacking. See our latest analysis for Royal Caribbean Cruises. With the share price now around $257.66 and a sharp 90 day share price return of about negative 27 percent following a strong year to date share price gain, it looks more like momentum is fading rather than building, despite...
NYSE:MDU
NYSE:MDUGas Utilities

Reassessing MDU Resources Group’s Valuation After Its Recent 90-Day Share Price Rally

MDU Resources Group (MDU) has quietly pulled back about 2% over the past month after a strong run in the past 3 months, which sets up an interesting check on its current valuation. See our latest analysis for MDU Resources Group. At a share price of $19.26, MDU’s 19.0% 90 day share price return contrasts with a modest 1 year total shareholder return of 2.0%. This suggests that recent momentum is rebuilding after a quieter stretch. If you are rethinking your utilities exposure, it can also be...
NasdaqGM:BCAX
NasdaqGM:BCAXBiotechs

How FDA Breakthrough Status And Early Data At Bicara Therapeutics (BCAX) Has Changed Its Investment Story

Bicara Therapeutics recently reported early Phase 1b expansion cohort data for its antibody-cytokine fusion ficerafusp alfa plus pembrolizumab in first-line HPV-negative recurrent/metastatic head and neck squamous cell carcinoma, alongside a Breakthrough Therapy Designation from the US FDA for this combination. These milestones highlight how regulators are signaling potential clinical relevance in a difficult-to-treat, biomarker-defined population, which could reshape expectations for...
NYSE:KBR
NYSE:KBRProfessional Services

KBR (KBR) Deepens F/A-18 Role: What Does This Say About Its Defense-Heavy Strategy?

KBR recently announced it has secured an estimated US$117 million cost-plus-fixed-fee follow-on contract to support NAVAIR’s F/A-18 and EA-18G Foreign Military Sales programs for Australia, Finland and Switzerland over five years. This award reinforces KBR’s long-running role in high-complexity defense aviation support, deepening its ties with U.S. and allied air forces while extending multiyear revenue visibility. We’ll now examine how this new F/A-18 support contract shapes KBR’s...
NYSE:BF.B
NYSE:BF.BBeverage

Brown‑Forman (BF.B) Margin Compression Reinforces Bearish Profitability Narratives After Q2 2026 Results

Brown Forman (BF.B) has just posted Q2 2026 results showing revenue of $1.0 billion and basic EPS of $0.47, backed by net income of $224 million as the spirits maker works through a period of softer margins. The company has seen quarterly revenue move from $1.1 billion in Q2 2025 to $1.0 billion in Q2 2026, with basic EPS shifting from $0.55 a year ago to $0.47 this quarter, while trailing twelve month net income came in at $810 million on revenue of $3.9 billion. Against a backdrop of lower...
NYSE:XPEV
NYSE:XPEVAuto

Are XPeng’s (XPEV) Rising November Deliveries Reinforcing Its Smart EV Scale‑Up Narrative?

XPeng Inc. has reported past delivery figures for November 2025, with 36,728 Smart EVs delivered for the month and year‑to‑date deliveries reaching 391,937 units, reflecting solid year‑over‑year growth in both metrics. This surge in monthly and cumulative deliveries highlights how XPeng’s current sales momentum may be interacting with its broader push into smart, software‑centric EVs. Next, we’ll examine how this strong November delivery performance shapes XPeng’s investment narrative around...
NYSE:FDX
NYSE:FDXLogistics

Will Grounded Cargo Jets During Peak Season Change FedEx's (FDX) Efficiency-Focused Investment Narrative?

In recent weeks, FedEx and UPS were forced to ground many aging cargo aircraft after a tragic explosion, cutting air capacity during the critical holiday shipping period and heightening reliance on alternative carriers such as the U.S. Postal Service and Amazon. This disruption underscores how concentrated fleets and older aircraft can amplify supply-chain risk, testing FedEx’s operational resilience just as peak-season efficiency matters most for customers and margins. We’ll now explore how...
NYSE:VOYA
NYSE:VOYADiversified Financial

Is Strong Q3 2025 Earnings and a Higher Dividend Altering The Investment Case For Voya Financial (VOYA)?

In the third quarter of 2025, Voya Financial reported adjusted operating earnings above expectations, fueled by higher fee and net investment income and stronger contributions from its Retirement and Employee Benefits businesses. The board’s decision to raise the quarterly dividend by 4% from the fourth quarter of 2025 highlights management’s confidence in sustaining capital returns through earnings strength and recent acquisitions. We’ll now examine how this better‑than‑expected earnings...
NasdaqGS:EZPW
NasdaqGS:EZPWConsumer Finance

Is EZCORP (EZPW) Still Undervalued After Its Recent Share Price Rally?

EZCORP (EZPW) has quietly delivered strong gains this year, and the move is catching investor attention. With the pawn and pre-owned retail business humming along, the recent rally raises fair questions about what is already priced in. See our latest analysis for EZCORP. The recent climb to a share price of $20.14, backed by a 30 day share price return of 11.89 percent and a 5 year total shareholder return of 294.90 percent, suggests momentum is still building as investors reassess EZCORP’s...
NasdaqGS:RGLD
NasdaqGS:RGLDMetals and Mining

Royal Gold (RGLD) Valuation After Dividend Hike, Record Q3 Revenue and Portfolio-Expanding Acquisitions

Royal Gold (RGLD) just gave income focused investors something to chew on, boosting its annual dividend by 6% alongside record third quarter revenue, even as earnings per share came in a bit light. See our latest analysis for Royal Gold. The latest dividend hike and portfolio expansion moves, including the Kansanshi Stream and Mount Milligan life extension, come as Royal Gold’s 30 day share price return of 16.35 percent and nearly 50 percent year to date share price gain signal building...
NYSE:USB
NYSE:USBBanks

Is U.S. Bancorp (USB) Still Undervalued After Its 18% Profit Jump and Fee Income Strength?

U.S. Bancorp (USB) just posted an 18% profit jump in its latest quarter, with net income climbing to $1.89 billion. This puts its fee businesses and recent stock strength squarely in the spotlight for investors. See our latest analysis for U.S. Bancorp. The $51.26 share price has been grinding higher in recent weeks, with a 1 month share price return of 9.67% that builds on a solid 3 year total shareholder return of 37.36%. This suggests momentum is gradually rebuilding as investors...
NasdaqGS:VRTX
NasdaqGS:VRTXBiotechs

Vertex (VRTX) Kidney Pipeline Upgrades: A Turning Point in Its Diversification Strategy?

Recently, Morgan Stanley and other analysts upgraded their views on Vertex Pharmaceuticals, citing growing confidence in its kidney disease pipeline, particularly povetacicept and inaxaplin, which are progressing through late-stage clinical trials. This renewed focus on Vertex’s kidney candidates highlights how successfully broadening beyond cystic fibrosis treatments could reshape the company’s long-term revenue mix and risk profile. We’ll now explore how this increased optimism around...
NYSE:CHD
NYSE:CHDHousehold Products

Does Church & Dwight’s 20% Share Price Slide in 2025 Signal a Long Term Opportunity?

If you have been wondering whether Church & Dwight is starting to look like quietly attractive value or just a quality name at the wrong price, you are not alone. The stock has drifted lower recently, with shares down about 0.8% over the last week, 2.5% over the past month and roughly 20.2% over the last year, even though the 3 year return is still positive at 9.4%. That pullback comes after a long run where defensive, household names like Church & Dwight were bid up as safe havens. The...
NYSE:MTH
NYSE:MTHConsumer Durables

Evaluating Meritage Homes (MTH) Valuation After a Year of Share Price Underperformance

Meritage Homes (MTH) has quietly lagged the market this year, with the stock down about 5% year-to-date and roughly 18% over the past year despite steady revenue and profit growth. See our latest analysis for Meritage Homes. At a share price of $72.23, Meritage’s 1 month share price return of nearly 9% hints that sentiment may be stabilising after a tougher stretch, even though the 1 year total shareholder return remains firmly negative. If Meritage’s recent rebound has you rethinking where...
NasdaqGM:DOMO
NasdaqGM:DOMOSoftware

Domo (DOMO) Narrows Q3 Net Loss, Testing Bearish Profitability Narratives

Domo (DOMO) has just put Q3 2026 on the books with revenue of about $79.4 million and a basic EPS loss of roughly $0.25, keeping the focus firmly on how efficiently the business is converting its topline into sustainable earnings. The company has seen quarterly revenue hover in a tight band around $78 million to $80 million over the past six reported periods, while EPS has similarly stayed in negative territory between approximately $0.25 and $0.56 per share, underscoring that margins remain...
NasdaqGS:NTRA
NasdaqGS:NTRABiotechs

Should Natera’s (NTRA) New Share Offering and Signatera Lymphoma Data Require Action From Investors?

Natera recently filed two shelf registrations to offer a combined 2,040,691 shares of common stock worth about US$478.72 million, alongside an employee stock plan–related tranche, while also preparing to present new clinical data on its Signatera test at the 2025 ASH Annual Meeting. The upcoming lymphoma data for Signatera, including earlier recurrence detection than imaging and use in NCCN-endorsed ctDNA-MRD assessment, may further strengthen its role in hematologic cancer management. We’ll...
NYSE:HPE
NYSE:HPETech

Hewlett Packard Enterprise (HPE): TTM Net Loss Challenges Bullish Margin-Recovery Narrative

Hewlett Packard Enterprise (HPE) has wrapped up FY 2025 with fourth quarter revenue of $9.7 billion, Basic EPS of $0.11, and net income of $146 million, putting a spotlight on how its margins are holding up late in the fiscal year. The company has seen revenue move from $8.5 billion and Basic EPS of $1.02 in Q4 2024 to $9.7 billion and $0.11 in Q4 2025. Over the same period, trailing twelve month EPS has swung from $1.95 to slightly negative, setting up a nuanced debate around the trade off...
NYSE:CWAN
NYSE:CWANSoftware

Will Clearwater’s Enfusion and Beacon Integration Shift CWAN’s Narrative Toward a Unified Institutional Platform?

Clearwater Analytics Holdings has acquired Enfusion and Beacon, moving beyond its insurance roots to offer a broader cloud-based investment accounting and analytics platform for asset managers and hedge funds, while maintaining a reported 98% gross retention rate and high new-business win rates. By integrating these acquired platforms into a single security master, Clearwater aims to simplify client workflows, improve operating efficiency and enhance its competitive edge in institutional...
NYSE:ICE
NYSE:ICECapital Markets

Intercontinental Exchange (ICE): Assessing Valuation After Strong November Volumes and New Contract Wins

Intercontinental Exchange (ICE) just strung together a trio of positive updates, with stronger November trading volumes, record open interest across key contracts, and extensions of major client relationships that reinforce its market infrastructure role. See our latest analysis for Intercontinental Exchange. Those operational wins are feeding into sentiment, with the latest $157.82 share price sitting above its start of year level and a strong three year total shareholder return suggesting...
NYSE:CNC
NYSE:CNCHealthcare

Assessing Centene’s (CNC) Valuation After a Sharp 3-Month Rebound and Ongoing Share Price Weakness

Centene (CNC) has quietly drifted lower this week, even after a strong past 3 months. That disconnect is catching some investors’ attention as they reassess what the recent rebound really implies. See our latest analysis for Centene. Even with a sharp 32.3% 3 month share price rebound, the stock is still nursing a heavy year to date share price loss, and multi year total shareholder returns remain deeply negative. This suggests sentiment is stabilising rather than fully turning bullish. If...
NYSE:HGV
NYSE:HGVHospitality

Hilton Grand Vacations (HGV): Assessing Valuation After Flat Revenue and a Miss on Analyst Expectations

Hilton Grand Vacations (HGV) just posted quarterly revenue of about $1.3 billion, essentially flat from last year. However, it landed roughly 5% below Wall Street’s expectations, raising fresh questions about execution. See our latest analysis for Hilton Grand Vacations. The muted revenue print helps explain why the 3 month share price return is down about 10 percent. Even though the year to date share price return is still positive and longer term total shareholder returns remain modest,...
NYSE:CCI
NYSE:CCISpecialized REITs

Is Crown Castle Offering Value After Recent Share Price Weakness and Cash Flow Outlook?

Wondering if Crown Castle is quietly becoming a value play while the market looks elsewhere? This is exactly the kind of setup where a closer look at valuation can pay off. The stock has been under pressure, with shares at around $89.28 and returns of -2.2% over the last week and -7.4% over the past year. This often signals shifting views on both growth prospects and risk. Recently, investors have been focused on Crown Castle's strategic moves around its tower and fiber assets, including...